Tenefovir, Emtriva and Fosamprenavir for wild type virus
Apr 9, 2006
Would Teneforvir, Emtriva and Fosamprenavir(not boosted with Retonavir) be a potent combo for myself who is found to carry wild type virus? The present regimen includes Kaletra and Retonavir which is giving me endless GI problems. I am hyper-sensitive to quite a few of the old HIV meds.So always looking for a better cocktail. cheers :)
Response from Dr. Young
Thanks for your post.
Though not (yet) formally tested, the combination of tenofovir (Viread), FTC (Emtriva; also available in combination with tenofovir as Truvada) with unboosted fosamprenavir (Lexiva, Telzir) should be quite well tolerated.
It's been our experience that even ritonavir (Norvir)-boosted fosamprenavir is very well tolerated; the unboosted strategy should probably be even better tolerated.
Just in case you (or our readers) were wondering unboosted atazanavir (Reyataz) should not be used with tenofovir, because tenofovir lowers the levels of atazanavir. Tenofovir + atazanavir combinations should include ritonavir.
Cheers back at you, BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Is Bronchitis A Symptom Of HIV?
- Is Flaky Skin A Symptom Of HIV?
- Dry Mouth After Oral Sex Form Sex Worker What Are The Chances Of HIV
- Flu Symptoms After Giving Handjob Worried I Have HIV
- Flu Symptoms After Open Mouth Kissing Worried I Have HIV
- Headache After Anal Sex With Condom Does It Mean I Have HIV
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.